DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 2 USDMF, 1 NDC API, 2 Listed Suppliers

3 API Suppliers
2 USDMF
1 NDC API
2 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers, 3 South Africa

3 FDF Dossiers
3 South Africa

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 1 DKSH, 3 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 12 BASF, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 5 Kerry, 10 Microlex e.U, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 17 Roquette, 1 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Fillers, Diluents & Binders, 24 Direct Compression, 17 Thickeners and Stabilizers, 14 Lubricants & Glidants, 12 Co-Processed Excipients, 12 Granulation, 11 Coating Systems & Additives, 10 Disintegrants & Superdisintegrants, 9 Controlled & Modified Release, 9 Film Formers & Plasticizers, 8 Solubilizers, 7 Parenteral, 7 Taste Masking, 5 Topical, 5 Chewable & Orodispersible Aids, 4 Emulsifying Agents, 1 Rheology Modifiers, 1 API Stability Enhancers

excipientsByApplications
42 Fillers, Diluents & Binders
24 Direct Compression
17 Thickeners and Stabilizers
14 Lubricants & Glidants
12 Co-Processed Excipients
12 Granulation
11 Coating Systems & Additives
10 Disintegrants & Superdisintegrants
9 Controlled & Modified Release
9 Film Formers & Plasticizers
8 Solubilizers
7 Parenteral
7 Taste Masking
5 Topical
5 Chewable & Orodispersible Aids
4 Emulsifying Agents
1 Rheology Modifiers
1 API Stability Enhancers

MARKET PLACE

4 APIs

marketPlace
4 APIs

REF. STANDARDS & IMPURITIES

2 USP , 1 Others

otherSolutions
2 USP
1 Others

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

108 RELATED EXCIPIENT COMPANIES

198EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 1176-08-5, Phenyltoloxamine citrate salt, 2-(2-benzylphenoxy)-n,n-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate, Nsc-169860, Mls000028598, Smr000058648

Molecular Formula

C₂₃H₂₉NO₈

Molecular Weight

447.5 g/mol

InChI Key

ZZYHCCDMBJTROG-UHFFFAOYSA-N

FDA UNII

8UE48MJH8M

1 2D Structure

Phenyltoloxamine Citrate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-(2-benzylphenoxy)-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid

2.1.2 InChI

InChI=1S/C17H21NO.C6H8O7/c1-18(2)12-13-19-17-11-7-6-10-16(17)14-15-8-4-3-5-9-15;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-11H,12-14H2,1-2H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)

2.1.3 InChI Key

ZZYHCCDMBJTROG-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CN(C)CCOC1=CC=CC=C1CC2=CC=CC=C2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O

2.2 Other Identifiers

2.2.1 UNII

8UE48MJH8M

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 1176-08-5

2. Phenyltoloxamine Citrate Salt

3. 2-(2-benzylphenoxy)-n,n-dimethylethanamine 2-hydroxypropane-1,2,3-tricarboxylate

4. Nsc-169860

5. Mls000028598

6. Smr000058648

7. 2-(2-benzylphenoxy)-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic Acid

8. Dsstox_cid_27770

9. Dsstox_rid_82547

10. Dsstox_gsid_47790

11. Cas-1176-08-5

12. Regid855695

13. Opera_id_1121

14. Phenyltoloxaminecitrate

15. Phenyltoloxamindihydrogencitrat

16. Mls001148667

17. Schembl158443

18. Chembl1586457

19. Dtxsid5047790

20. Hms2231p03

21. Hms3372c22

22. Baa17608

23. Tox21_110862

24. Nsc148352

25. Nsc169860

26. Tox21_110862_1

27. Nsc-148352

28. 2-(2-benzylphenoxy)-n,n-dimethylethanamine2-hydroxypropane-1,2,3-tricarboxylate

29. Phenyltoloxamine Citrate [mart.]

30. Phenyltoloxamine Citrate [vandf]

31. Ncgc00021141-05

32. Phenyltoloxamine Citrate [usp-rs]

33. Phenyltoloxamine Citrate [who-dd]

34. Db-041377

35. Wln: 1n1&2or B1r &ov1xqvo&1vo

36. Ft-0603550

37. D08967

38. Phenyltoloxamine Citrate [usp Monograph]

39. Phenyltoloxamine Dihydrogen Citrate [mi]

40. Phenyltoloxamine Dihydrogen Citrate [vandf]

41. Sr-01000003146

42. Sr-01000003146-3

43. W-109651

44. N,n-dimethyl-2([alpha-phenyl-o-tolyl]oxy)ethylamine

45. Q27271029

46. Phenyltoloxamine Citrate 1.0 Mg/ml In Methanol (as Free Base)

47. Ethylamine,n-dimethyl-2-[(.alpha.-phenyl-o-tolyl)oxy]-, Citrate (1:1)

48. N,n-dimethyl-(a-phenyl-o-toloxy) Ethylamine Dihydrogen Citrate

49. N,n-dimethyl-2-(.alpha.-phenyl-o-toloxy)ethylamine Dihydrogen Citrate

50. N,n-dimethyl-2-(.alpha.-phenyl-o-tolyloxy)ethylamine, Citrate (1:1) Salt

51. Phenyltoloxamine Citrate, United States Pharmacopeia (usp) Reference Standard

52. Ethanamine,n-dimethyl-2-[2-(phenylmethyl)phenoxy]-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)

2.4 Create Date

2005-03-26

3 Chemical and Physical Properties

Molecular Formula	C₂₃H₂₉NO₈
Molecular Weight	447.5 g/mol
Hydrogen Bond Donor Count	4
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	11
Exact Mass	447.18931688 g/mol
Monoisotopic Mass	447.18931688 g/mol
Topological Polar Surface Area	145 Å²
Heavy Atom Count	32
Formal Charge	0
Complexity	463
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

API SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

South Africa

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

Direct Compression

Thickeners and Stabilizers

Lubricants & Glidants

Co-Processed Excipients

Granulation

Coating Systems & Additives

Disintegrants & Superdisintegrants

Controlled & Modified Release

Film Formers & Plasticizers

Solubilizers

Parenteral

Taste Masking

Topical

Chewable & Orodispersible Aids

Emulsifying Agents

Rheology Modifiers

API Stability Enhancers

Market Place

Do you need sourcing support? Ask us

APIs

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

USP

Others

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Find Phenyltoloxamine Citrate manufacturers, exporters & distributors on PharmaCompass

Phenyltoloxamine Citrate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers

2 USDMF

1 NDC API

2 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers

3 South Africa

RELATED EXCIPIENT COMPANIES

4 SPI Pharma

1 DKSH

3 Faran Shimi Pharmaceutical

1 Boai NKY Pharmaceuticals Ltd

10 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Pfanstiehl

3 Actylis

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

12 BASF

2 DFE Pharma

1 Finar

6 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

2 Ingredion Pharma Solutions

5 Kerry

10 Microlex e.U

1 Novo Excipients

2 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

17 Roquette

1 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

8 Sigachi Industries

1 Valens Pharmachem

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Fillers, Diluents & Binders

24 Direct Compression

17 Thickeners and Stabilizers

14 Lubricants & Glidants

12 Co-Processed Excipients

12 Granulation

11 Coating Systems & Additives

10 Disintegrants & Superdisintegrants

9 Controlled & Modified Release

9 Film Formers & Plasticizers

8 Solubilizers

7 Parenteral

7 Taste Masking

5 Topical

5 Chewable & Orodispersible Aids

4 Emulsifying Agents

1 Rheology Modifiers

1 API Stability Enhancers

MARKET PLACE

4 APIs

REF. STANDARDS & IMPURITIES

2 USP

1 Others

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

108 RELATED EXCIPIENT COMPANIES

198EXCIPIENTS BY APPLICATIONS